The Legacy of Theranos: Innovations in Blood Testing

This chapter examines the lasting effects of the Theranos scandal on blood testing technology and the healthcare industry. It highlights the ongoing challenges and advancements in creating reliable and efficient testing methods, as well as the regulatory implications that have emerged in its wake. The discussion emphasizes the delicate balance needed between fostering innovation and ensuring patient safety through proper oversight.